SequelSEC

Personalis, Inc. PSNL

Services-Medical Laboratories · CIK 0001527753 · Fiscal year ends 1231

Revenue
$69.67M
Fiscal year ended 2026-06-30
Operating income
-$114.31M
Fiscal year ended 2026-06-30
Free cash flow
-$100.98M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$578.18MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$5.53Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue8.3×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.2×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Medical Laboratories filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Revenue YoY growth-17.7%5th
FCF margin-114.1%18th
Net margin-116.7%19th
Operating margin-126.4%19th
R&D / revenue72.2%75th
SBC / revenue13.5%75th
Current ratio6.76x72th
CapEx / revenue6.5%71th
Gross margin22.7%33th

Personalis, Inc. (PSNL) reported revenue of $69.67M and net income of -$107.18M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Personalis, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Medical Laboratories.

Income

Personalis, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$69.67M
Cost of revenue$60.83M
Gross profit$8.84M
Operating income-$114.31M
Net income-$107.18M
Research & development$56.12M
Weighted-average diluted sharesUnavailable
Pretax income-$107.15M
Income tax expense$33.00K
Diluted EPSUnavailable
Selling, general & administrative$67.03M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Personalis, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$93.97M
Total assets$312.14M
Current assets$245.05M
Total liabilities$76.97M
Current liabilities$46.38M
Total equity incl. NCI$235.16M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$15.10M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$16.00M

Cash flow

Personalis, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$92.30M
Capital expenditures$8.68M
Investing cash flow-$3.50M
Financing cash flow$136.40M
Net change in cash$40.59M
Stock-based compensation$10.91M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$9.65M

Derived

Personalis, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$100.98M
Gross margin12.7%
Operating margin-164.1%
FCF margin-144.9%
SBC / revenue15.7%
Current ratio5.28x
Revenue YoY growth-13.3%
Net margin-153.8%
R&D / revenue80.5%
CapEx / revenue12.5%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PSNL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-04View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-06View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.